{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:45:52Z","timestamp":1790199952032,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-026-05360-z","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:28:40Z","timestamp":1774513720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Developing a framework for pharmaceutical care practices of herbal and dietary supplements in hospital settings: a mixed methods approach"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-316X","authenticated-orcid":false,"given":"Annie","family":"Paisansirikul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-970X","authenticated-orcid":false,"given":"Mayuree","family":"Tangkiatkumjai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"5360_CR1","unstructured":"World Health Organization. WHO global report on traditional and complementary medicine 2019. Geneva: World Health Organization. 2019. ISBN 978-92-4-151543-6. https:\/\/www.who.int\/publications\/i\/item\/978924151536"},{"key":"5360_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2147\/JMDH.S212953","volume":"12","author":"K Peltzer","year":"2019","unstructured":"Peltzer K, Pengpid S. The use of herbal medicines among chronic disease patients in Thailand: a cross-sectional survey. J Multidiscip Healthc. 2019;12:573\u201382.","journal-title":"J Multidiscip Healthc"},{"key":"5360_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1472-6882-13-153","volume":"13","author":"M Tangkiatkumjai","year":"2013","unstructured":"Tangkiatkumjai M, Boardman H, Praditpornsilpa K, et al. Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey. BMC Complement Altern Med. 2013;13:153.","journal-title":"BMC Complement Altern Med"},{"key":"5360_CR4","doi-asserted-by":"publisher","unstructured":"Thangsuk P, Pinyopornpanish K, Jiraporncharoen W et al. Is the Association between Herbal Use and Blood-Pressure Control Mediated by Medication Adherence? A Cross-Sectional Study in Primary Care. Int J Environ Res Public Health. 2021;18(24). https:\/\/doi.org\/10.3390\/ijerph182412916","DOI":"10.3390\/ijerph182412916"},{"key":"5360_CR5","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.hermed.2020.100391","volume":"24","author":"C Sornchaithawatwong","year":"2020","unstructured":"Sornchaithawatwong C, Tadtong S, Tangkiatkumjai M. The prevalence of acceptable quality herbal products in Thailand. J Herb Med. 2020;24:100391.","journal-title":"J Herb Med"},{"issue":"1","key":"5360_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2008-2231-20-18","volume":"20","author":"M Kazemi","year":"2012","unstructured":"Kazemi M, Eshraghi A, Yegdaneh A, et al. Clinical pharmacognosy- A new interesting era of pharmacy in the third millennium. Daru. 2012;20(1):18.","journal-title":"Daru"},{"key":"5360_CR7","unstructured":"International Pharmaceutical Federation. Good Pharmacy Practice. 2012. https:\/\/www.fip.org\/file\/1476. Accessed 25 Aug 2025."},{"issue":"1","key":"5360_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4321\/S1886-36552008000100006","volume":"6","author":"J Farrell","year":"2008","unstructured":"Farrell J, Ries NM, Boon H. Pharmacists and Natural Health Products: A systematic analysis of professional responsibilities in Canada. Pharm Pract (Granada). 2008;6(1):33\u201342.","journal-title":"Pharm Pract (Granada)"},{"issue":"3","key":"5360_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.sapharm.2022.11.001","volume":"19","author":"JE Harnett","year":"2023","unstructured":"Harnett JE, Lam Ung CO. Towards defining and supporting pharmacists\u2019 professional role associated with traditional and complementary medicines \u2013 A systematic literature review. Res Social Administrative Pharm. 2023;19(3):356\u2013413.","journal-title":"Res Social Administrative Pharm"},{"key":"5360_CR10","doi-asserted-by":"publisher","first-page":"1215475","DOI":"10.3389\/fphar.2023.1215475","volume":"14","author":"JE Harnett","year":"2023","unstructured":"Harnett JE, Desselle SP, Fernandes MB, et al. Defining and supporting a professional role for pharmacists associated with traditional and complementary medicines: a cross-country survey of pharmacists. Front Pharmacol. 2023;14:1215475.","journal-title":"Front Pharmacol"},{"issue":"4","key":"5360_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.sapharm.2016.08.001","volume":"13","author":"COL Ung","year":"2017","unstructured":"Ung COL, Harnett J, Hu H. Community pharmacist\u2019s responsibilities with regards to traditional medicine\/complementary medicine products: A systematic literature review. Res Social Adm Pharm. 2017;13(4):686\u2013716.","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"5360_CR12","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.18549\/PharmPract.2022.3.2697","volume":"20","author":"SM Thin","year":"2022","unstructured":"Thin SM, Thet D, Li JY, et al. A systematic review of community pharmacist practices in complementary medicine. Pharm Pract (Granada). 2022;20(3):2697.","journal-title":"Pharm Pract (Granada)"},{"issue":"1","key":"5360_CR13","first-page":"97","volume":"4","author":"T Kanjanarach","year":"2008","unstructured":"Kanjanarach T, Krass I, Cumming RG. Pharmacists\u2019 Responsibilities with Respect to Dietary Supplements: Perceptions of Thai Community and Hospital Pharmacists. Isan J Pharm Sci. 2008;4(1):97\u2013105.","journal-title":"Isan J Pharm Sci"},{"key":"5360_CR14","doi-asserted-by":"publisher","unstructured":"Wahab MSA, Sakthong P, Winit-Watjana W. Qualitative exploration of pharmacist care for herbal and dietary supplement users in Thai community pharmacies. 2019;10(1):57\u201366. https:\/\/doi.org\/10.1111\/jphs.12238","DOI":"10.1111\/jphs.12238"},{"issue":"3","key":"5360_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.aimed.2018.01.003","volume":"5","author":"L Alnaim","year":"2018","unstructured":"Alnaim L, Almazrou S, Alsunbul M, et al. Pharmacist\u2019s knowledge and attitudes towards complementary and alternative medicine in Saudi Arabia: A cross-sectional study. Adv Integr Med. 2018;5(3):96\u2013102.","journal-title":"Adv Integr Med"},{"key":"5360_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.29090\/psa.2021.04.20.059","volume":"48","author":"W Worakunphanich","year":"2021","unstructured":"Worakunphanich W, Thongsombutpanitch F, Nilsonthi S, et al. Knowledge, attitude and practice of traditional medicine-related adverse drug reaction (ADR) reporting among hospital pharmacists and traditional medicine practitioners in Thailand. Pharm Sci Asia. 2021;48:330\u20138.","journal-title":"Pharm Sci Asia"},{"issue":"6","key":"5360_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"5360_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"5360_CR19","doi-asserted-by":"publisher","first-page":"100174","DOI":"10.1016\/j.ijnsa.2024.100174","volume":"6","author":"S Rahimi","year":"2024","unstructured":"Rahimi S, Khatooni M. Saturation in qualitative research: An evolutionary concept analysis. Int J Nurs Stud Adv. 2024;6:100174.","journal-title":"Int J Nurs Stud Adv"},{"issue":"3","key":"5360_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11096-014-9933-x","volume":"36","author":"SS Allemann","year":"2014","unstructured":"Allemann SS, van Mil JWF, Botermann L, et al. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544\u201355.","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"5360_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.sapharm.2017.07.012","volume":"14","author":"COL Ung","year":"2018","unstructured":"Ung COL, Harnett J, Hu H. Development of a strategic model for integrating complementary medicines into professional pharmacy practice. Res Social Adm Pharm. 2018;14(7):663\u201372.","journal-title":"Res Social Adm Pharm"},{"key":"5360_CR22","first-page":"49","volume":"2","author":"RJ Rovinelli","year":"1977","unstructured":"Rovinelli RJ, Hambleton RK. On the use of content specialists in the assessment of criterion-referenced test item validity. Dutch J Edu Res. 1977;2:49\u201360.","journal-title":"Dutch J Edu Res"},{"issue":"1","key":"5360_CR23","first-page":"3","volume":"29","author":"G Guest","year":"2017","unstructured":"Guest G, Namey E, McKenna K. How Many Focus Groups Are Enough? Building an Evidence Base for. Nonprobability Sample Sizes. 2017;29(1):3\u201322.","journal-title":"Nonprobability Sample Sizes"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05360-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05360-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05360-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:15:52Z","timestamp":1777943752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05360-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5360"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05360-z","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the present study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee, as well as with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (No. 0455\/2024) on March 23, 2024. Informed consent was obtained from all individual participants included in the study. The research adhered to the consolidated criteria for reporting qualitative research (COREQ) [\n                      \n                      ] and the strengthening of the reporting of observational studies in epidemiology (STROBE) statement [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}